SAN FRANCISCO: The California Institute for Regenerative Medicine, the state agency that rewards grants for stem cell research, recently chose Fleishman-Hillard for a $115,000 contract to aid the organization's goal to become a thought leader in the field of stem cell research.
CIRM was created after California voters approved a 2004 ballot initiative to provide $3 billion in funds to state universities and research facilities for stem cell research.
Fleishman will provide media monitoring, opinion leader research in the business community, leadership media training, and strategic high-level media placement, according to Don Gibbons, chief communications officer at CIRM.
Gibbons said CIRM issued an RFP in June and five other firms pitched: Weber Shandwick, GCI Group, Burson-Marsteller, Feinstein Kean Healthcare, and WunderMarx PR.
A CIRM RFP issued late last year with a $300,000 budget was put on hold. Gibbons said he declined to pursue that project, which nine agencies responded to, because the RFP was too broad.